Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Saline breast implant research

This article was originally published in The Gray Sheet

Executive Summary

Potential autoimmune reaction to breast implants may be linked to the implants' silicone shell and not the contents of the prostheses, Henry Claman, MD, University of Colorado Health Sciences Center, Denver, reports to FDA. Both saline- and silicone gel-filled breast implants employ a silicone shell. In Jan. 26 comments on FDA's proposed call for saline-filled breast implants, Claman says his study results found that "there was no correlation between antinuclear antibody [ANA] positivity," which indicates autoimmune response, and the type of implant. "Thus, a positive ANA might be related to the silicone shell rather than the contents." Claman's research on over 100 patients recently was submitted to the Western Journal of Medicine.

You may also be interested in...



Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000177

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel